Titlebook: Advances in Diagnosis and Management of Ovarian Cancer; Samir A. Farghaly Book 2022Latest edition Springer Nature Switzerland AG 2022 Canc

遮陽傘

書目名稱Advances in Diagnosis and Management of Ovarian Cancer影響因子(影響力)




書目名稱Advances in Diagnosis and Management of Ovarian Cancer影響因子(影響力)學(xué)科排名




書目名稱Advances in Diagnosis and Management of Ovarian Cancer網(wǎng)絡(luò)公開度




書目名稱Advances in Diagnosis and Management of Ovarian Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Advances in Diagnosis and Management of Ovarian Cancer被引頻次




書目名稱Advances in Diagnosis and Management of Ovarian Cancer被引頻次學(xué)科排名




書目名稱Advances in Diagnosis and Management of Ovarian Cancer年度引用




書目名稱Advances in Diagnosis and Management of Ovarian Cancer年度引用學(xué)科排名




書目名稱Advances in Diagnosis and Management of Ovarian Cancer讀者反饋




書目名稱Advances in Diagnosis and Management of Ovarian Cancer讀者反饋學(xué)科排名

高興一回

Management of Epithelial Ovarian Cancer with Peritoneal Metastases,978-1-349-17316-7

變態(tài)

Targeted Molecular Therapy for Ovarian Cancer Patients,978-1-349-02104-8

MENT

Advances in Diagnosis and Management of Ovarian Cancer

發(fā)現(xiàn)

Advances in Diagnosis and Management of Ovarian Cancer978-3-031-09169-8

separate

打折

The Classification of Calcium Antagonists an earlier stage, they are not cost-effective and are not likely to decrease the overall mortality significantly. It is hoped that ovarian cancer precursors can be detected using cytology or by examining molecular signatures to provide early detection and reduction of mortality from ovarian cancer.

留戀

S. Sampaolo,N. Heye,J. Cervos-NavarroAlgorithm (ROMA), and Overa. However, recently, gene, metabolite, epigenetics, and miRNA-based biomarkers have been studied. Another accelerating area of cancer biomarkers is liquid biopsy as a noninvasive approach because of the challenges in the detection of small nonmetastatic tumors in early sta

萬神殿

變量